Igor Vorobey fell for tax fraud

The Investigative Committee of the Russian Federation detained the head of the RIA "Panda", producing dietary supplements to enhance the potency of "Sealeks" and "Alikaps." Probably, foreign businessmen can stand behind the arrest of a businessman.
Origin source
In St. Petersburg, the owner and general director of RIA Panda was detained. He is accused of evading taxes for more than 1 billion 260 million rubles. This is reported by the CSG of the IC of St. Petersburg. According to SPARK, Igor Vorobey is the general director of RIA Panda. The same person is listed as the general director of OOO Pharmaceutical Company RIA Panda in the data of the USRLE.

According to the investigation, Sparrow, acting on behalf of RIA Panda, together with unidentified persons, consistently included in the tax returns on the value-added tax deliberately false information, which entailed incomplete payment of taxes and fees. " In the UK explained that this is a period from January 2013 to March 2015.

In 2017, the Investigative Committee already reported on the criminal case of non-payment of taxes by the company RIA Panda, then it was about the amount of 144 million rubles.

Pharmaceutical company "RIA Panda" specializes in the production and sale of biologically active additives (BAA), including for potentiation. At the end of March 2018, the Arbitration Court of St. Petersburg and the Leningrad Region began proceedings on the bankruptcy case of the company on the application of Media Instinct. This is an advertising agency, which, according to the statement of claim, the company Igor Vorobyov should about 12 million rubles.

Earlier, in 2016, Rospotrebnadzor canceled the certificates of state registration of the two most famous drugs, which was issued by RIA Panda - Alikapsa and Sealex Forte. Then the media reported that the drugs are in the top 10 dietary supplements by the volume of pharmacy sales in Russia. Despite the release of dietary supplements with a similar name (they did not apply the ban), in 2016 the company reduced sales of drugs by half and lost its position in the ranking of the largest sellers of additives, moving from the second line to the third.

In the fall of 2017, tax officials filed an application for the recognition of RIA Panda bankrupt, but the court has not yet accepted it for consideration. The document specified the amount of the claim - more than 2 billion rubles.

In December 2017 the company dropped to the eighth place in the ranking of the largest sellers of dietary supplements in Russia. By that time, the number of claims from creditors filed against RIA Panda exceeded 30.

According to the information on the company's website, in the portfolio of "RIA Panda" more than 50 drugs and more than 175 titles. According to SPARK, in 2016 the company's revenue amounted to more than 3 billion rubles. (against 4.8 billion rubles in 2014 and almost 4.3 billion rubles in 2015), net profit in 2016 - about 188 million rubles. (about 368.5 million rubles in 2015 and almost 269.5 million rubles in 2014).